Keith T Flaherty

Assistant Professor of Medicine at the Presbyterian Medical Center of Philadelphia

Department: Medicine

Contact information

University of Pennsylvania Medical Center
Department of Medicine, Division of Hematology/Oncology
34th & Spruce Streets
12 Penn Tower
Philadelphia, PA 19104

Office: (215) 662-7402
Fax: (215) 349-8550

Email:
ktflaherty@aol.com

Education
B.S. (Neurobiology)
Yale University, 1993.
M.D.
Johns Hopkins University, 1997.

Permanent link

School of Medicine > Faculty > Search

Description of Research Expertise

Experimental therapies

Description of Clinical Expertise

Melanoma
Renal cell carcinoma

Selected Publications

Flaherty KT, Malkowicz SB, Vaughn DJ: A Phase I Study of Weekly Liposome-encapsulated Doxorubicin in Patients with Advanced, Androgen-independent Prostate Cancer. Am J Clin Oncol. 27(2): 136-9, Apr 2004.

Flaherty KT, Stevenson JP, Redlinger M, Giantonio B, Algazy KM, O’Dwyer PJ: A Phase I, Dose Escalation Trial of ZD0473, a Novel Platinum Analogue, in Combination with Gemcitabine. Cancer Chemother Pharmacol. Jan 29 2004.

Bilenker JH, Stevenson JP, Flaherty KT, Algazy K, McLaughlin K, Haller DG, Giantonio BJ, Koehler M, Garcia-Vargas JE, O'Dwyer PJ. : Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies. Cancer Chemother Pharmacol. 53(4): 357-60, Apr 2004.

Flaherty KT: New molecular targets in melanoma. Curr Opin Oncol. 16(2): 150-4, Mar 2004.

Flaherty KT., Stevenson JP., Hahn SM., Redlinger M., O'Dwyer PJ.: Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy. Cancer Chemotherapy & Pharmacology 52(3): 217-22, Sep 2003.

Flaherty KT., Stevenson JP., Gallagher M., Giantonio B., Algazy KM., Sun W., Haller DG., O'Dwyer PJ.: Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer. Cancer 97(8): 1985-90, Apr 15 2003.

Flaherty KT, Tuveson D, Brose M, Rosen M, Lee RJ, Schwartz B, Schuchter LM, O’Dwyer PJ: Pharmacodynamic Study of BAY 43-9006 in Patients with Renal Cell Carcinoma and Melanoma. NCI-AACR-EORTC 2003, poster #A84. 2003.

Flaherty KT, Lee RJ, Humphrey R, O’Dwyer PJ, Schiller J: Phase I trial of BAY 43-9006 in combination with carboplatin and paclitaxel. ASCO 2003, oral presentation, abstract #2854 2003.

Flaherty KT, O’Dwyer PJ: Phase II trials: Conventional Design and Novel Strategies in the Era of Targeted Therapy. Anticancer Drug Development Guide. Teicher BA (eds.). Feb 2003 Notes: In press.

Tao J., Flaherty K., Bagg A.: Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosis. Journal of Clinical Oncology 20(17): 3737-9, Sep 1 2002.